Alex Sirois

Alex Sirois

InvestorPlace Contributor

Alex is a freelance contributor to InvestorPlace who provides investment insight that is conversational, actionable, and educational. While he writes about all stock classes, his personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks.

Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing. His number one goal in writing for InvestorPlace is to bring value to the reader.

You can follow Alex on LinkedIn.

Recent Articles

GE Stock Is Set To Ride Massive Wind Energy Demand Higher

By Alex Sirois, InvestorPlace Contributor

GE stock enjoyed a renaissance prior to the pandemic. A good part of that comeback story hinges on wind power moving forward.

It’s a Good Time to Buy PENN Stock Prior to the Q2 Earnings Release

By Alex Sirois, InvestorPlace Contributor

PENN stock suffered during the pandemic as businesses did everywhere. It is set up to deliver strong results on Aug. 5

Alibaba Stock Faces Risks, But It Should Climb Over the Long Term

By Alex Sirois, InvestorPlace Contributor

BABA stock is cheap right now and there's little to suggest investors should be fearful about its long-term prospects.

Li Auto’s YTD Offers a Glimpse of a Bright Future for Long-Term Investors

By Alex Sirois, InvestorPlace Contributor

LI stock represents ownership in a burgeoning Chinese EV manufacturer with plenty to be interested in. Delivery trajectory looks strong.

Crispr Therapeutics Represents the Best of Emerging Biotechnology

By Alex Sirois, InvestorPlace Contributor

CRSP stock may end up being a pioneer, or it may fizzle. The timeline until we know is typical of biotech stocks.

Load More